Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations

• Status: Unknown status
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the effectiveness of bleomycin, fibrovein and bleomycin and fibrovein in the treatment of venous malformation.

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Oslo University Hospital
• Treatments: Bleomycin

Criteria

Inclusion Criteria:

Venous malformation

Exclusion Criteria:

kidney and lung disease